Qiagen N.V. (QGEN)

業務介紹

祈安公司(QIAGEN N.V.)提供從生物材料到分子洞見的全流程解決方案,服務於全球市場。該公司提供主要樣本技術耗材,如核酸穩定和純化試劑盒,用於基因分型、基因表達以及病毒和細菌分析的手動和自動化處理,以及硅膜和磁珠技術;次級樣本技術耗材,包括用於核酸純化的試劑盒和組件;以及核酸純化儀器和配件。它還提供用於TB檢測的干擾素-γ釋放檢測,以及用於移植後檢測和病毒載量監測的檢測;用於產前檢測、性傳播疾病和HPV檢測的檢測,以及用於基因組變異(如突變、插入、缺失和融合)分析的檢測;以及用於難診斷綜合徵的一步分子分析和綜合PCR檢測的樣本到洞見儀器。此外,它還提供定量PCR、反轉錄和基因表達、基因分型和基因調控分析的PCR耗材和儀器技術;包括STR檢測在內的人類鑑定和法醫檢測耗材,以及食品污染檢測;數字PCR解決方案的PCR儀器;以及開發和配置的OEM耗材。該公司還提供預定義和定制的NGS基因組板、文庫製備試劑盒和組件,以及全基因組擴增;QIAGEN耗材和儀器,以及生物信息學解決方案;以及定制實驗室和基因組服務。它為分子診斷、學術界、製藥和應用檢測客戶提供服務。它與Sysmex Corporation和OncXerna Therapeutics有戰略聯盟協議,並與Mirati有協議。該公司成立於1986年,總部位於荷蘭的芬洛。



QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

公司網址

https://www.qiagen.com